Haemonetics CORP 8-K filings

NYSE

8 Feb 2024

HAE

8-K: Haemonetics Reports Strong Q3 Results and Updates Fiscal 2024 Guidance

Haemonetics Corporation announced positive third quarter fiscal 2024 results, with revenue growth and increased profitability, leading to an updated fiscal year guidance.